(EMAILWIRE.COM, November 30, 2018 ) The growth of this market is driven by the growth in the geriatric population and corresponding age-related chronic diseases, epidemiological shift from infectious to chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical complications occurred due to post-surgical adhesion formation.

Adhesion Barrier Market, By Product

Synthetic Adhesion Barriers
-Hyaluronic Acid
-Regenerated Cellulose
-Polyethylene Glycol
-Other Synthetic Adhesion Barrers*
Natural Adhesion Barriers
-Collagen & Protein
-Fibrin

Download FREE Brochure: https://tinyurl.com/yacp8eac

Based on the product type synthetic adhesion barriers accounted for the largest share of the market in 2017, owing to the benefits offered by synthetic adhesion barriers, such as high biocompatibility, bioresorbable property, which eliminates the need for a second surgery for the removal of the implant, and cost-effective as compared to natural adhesion barrier.

The major players in the adhesion barrier market are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).

The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.

Request Free Sample Report: https://tinyurl.com/yccpx9yx

North America holds the largest share of this market in 2017. This is primarily due to the increase in the aging population, increasing number of soft tissue injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, and well-established healthcare services across North America.

Johnson & Johnson (J&J) (US), Sanofi (France), and Baxter International (US) dominated the global adhesion barrier market in 2017. Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).